In GBM, LUSC, TGCT, BRCA, COAD and THCA, YTHDF1 is negatively related with ICP genes, which means that high YTHDF1 expression might predict unsatisfying immunotherapy outcomes when targeting ICP genes. The gene discussed is YTHDF1; the disease is glioblastoma.